Apple Watch is getting a new high blood pressure notification feature that's distinct from the hypertension alerts already available in watchOS 26. A Digitimes report says Apple has submitted the feature to the FDA for review, though the public can't access it yet. Details on how this differs from the existing alerts remain fuzzy.

watchOS 26 brought hypertension alerts to Apple Watch last fall, but this new feature appears to offer something different. Digitimes mentions it alongside Apple Watch Ultra 4 details, which could indicate a launch with upcoming models. The report also hints that after this blood pressure feature clears FDA review, Apple's next health push may target noninvasive blood-glucose monitoring—a long-sought capability.

The report doesn't clarify what makes this new blood pressure feature distinct or pin down a release date. What's clear is that Apple continues sharpening the Apple Watch's health management appeal by pursuing increasingly sophisticated biometric features. The FDA review status suggests the company is closer to launching something that could rival traditional medical devices.